Acute generalized exanthematous pustulosis with erythema multiforme‐like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID‐19) (original) (raw)

Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19

BENOIT BENSAID

The Journal of Allergy and Clinical Immunology: In Practice, 2020

View PDFchevron_right

Hydroxychloroquine‐induced acute generalized exanthematous pustulosis: an adverse reaction to keep in mind during COVID‐19 pandemic

Raquel Rivera Díaz

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2021

View PDFchevron_right

Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID‐19 without hydroxychloroquine use: Report of the first case

Babar Rao

Journal of Cosmetic Dermatology, 2021

View PDFchevron_right

Drug eruption: A mimicker of Coronavirus disease-2019 rash

tülin Ergun

TURKDERM, 2022

View PDFchevron_right

Authors' reply to: ‘Generalized pustular figurate erythema first report in two COVID ‐19 patients on hydroxychloroquine’

LINDA TOGNETTI

Journal of the European Academy of Dermatology and Venereology

View PDFchevron_right

Acute Generalized Exanthematous Pustulosis After COVID‐19 Infection: A Case Report From Saudi Arabia

Malak Alzahrani

Cureus, 2020

View PDFchevron_right

Role of Drug Hypersensitivity in the Cutaneous Manifestations of SARS-CoV-2 Infection

María Laura García Bermejo

Journal of Investigational Allergy and Clinical Immunology

View PDFchevron_right

Severe adverse drug reaction in SARS‐CoV ‐2 infection: AGEP induced by ceftriaxone and confirmed by patch test

Francesco Di Candilo

Contact Dermatitis, 2021

View PDFchevron_right

A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)

Farah Marraha

Dermatology Research and Practice, 2020

View PDFchevron_right

Cutaneous Eruption in COVID-19 in Two Cases: Side Effects Drugs or Viral Manifestation?

Mariam Lagrine

International Journal of Advanced Research, 2020

View PDFchevron_right

A Case of Fever and Polymorphous Rash in a Patient with Recent SARS-COV-2 Infection

Nikolaos Kakaletsis

Archives of the Balkan Medical Union

View PDFchevron_right

Lornoxicam-induced acute generalized exanthematous pustulosis

Houssem HMOUDA

International journal of dermatology, 2016

View PDFchevron_right

Cutaneous Manifestations in Patients with COVID-19: A Review

Fortune Journals

View PDFchevron_right

Skin rash induced by ritonavir-boosted darunavir is common, but generally tolerable in an observational setting

Hiroyuki Gatanaga

Journal of Infection and Chemotherapy, 2014

View PDFchevron_right

Reticular rash in drug reaction with eosinophilia and systemic symptoms syndrome: A clue to parvovirus B19 reactivation?

Luis Mazzuoccolo

JAAD case reports, 2018

View PDFchevron_right

Clinical Features and Etiology of Adult Patients with Fever and Rash

Aysan Murtezaoglu, Zekayi Kutlubay, Fehmi Tabak

Annals of Dermatology, 2012

View PDFchevron_right

Histological pattern in Covid‐19 induced viral rash

Cosimo Misciali

Journal of the European Academy of Dermatology and Venereology

View PDFchevron_right

The dermatologic manifestations of COVID-19: a mini-review

Sabah Alharazy

Annals of proteomics and bioinformatics, 2021

View PDFchevron_right

Toxic epidermal necrolysis in a patient infected with human immunodeficiency virus-2

Isabel Da Franca

Journal of the European Academy of Dermatology and Venereology, 2002

View PDFchevron_right

Cutaneous Manifestations in Adult Patients with COVID-19 and Dermatologic Conditions Related to the COVID-19 Pandemic in Health Care Workers

Althea Diaz

Current Allergy and Asthma Reports, 2020

View PDFchevron_right

Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review

Roberta Giuffrida

Biology

View PDFchevron_right

Ixekizumab for treatment of refractory acute generalized exanthematous pustulosis caused by hydroxychloroquine

Mohammad Munshi

JAAD Case Reports, 2020

View PDFchevron_right

Dermatological Manifestations of COVID-19: A Review Based on Existing Reports

sameer khasbage

International Journal of Current Research and Review

View PDFchevron_right

Skin rash associated with atazanavir: report of three cases

zineb ouagari

AIDS, 2006

View PDFchevron_right

Purpuric Skin Rash in a Patient Undergoing Pfizer-BioNTech COVID-19 Vaccination: Histological Evaluation and Perspectives

Gerardo Cazzato

Vaccines

View PDFchevron_right

PHARMACEUTICAL SCIENCES SJIF Impact Factor: 7.187 LITERATURE REVIEW OF CUTANEOUS MANIFESTATIONS OF COVID-19

Dlal Ahmed, Sarah Alobud, Editor iajps

View PDFchevron_right

Cutaneous reactions following CoronaVac COVID‐19 vaccination: a case series of six healthcare workers from a single centre

Betül Öğüt

Journal of the European Academy of Dermatology and Venereology, 2021

View PDFchevron_right

Urticaria and Angioedema in a Patient Diagnosed with COVID-19: Case Report

Sedat Kaygusuz

Flora, 2021

View PDFchevron_right

Dermatologic Manifestation Of COVID-19: Review Of Case Series Review Article

International Journal of Clinical Dermatology & Research (IJCDR)

SciDoc Publishers, 2021

View PDFchevron_right

Viral Infections and Cutaneous Drug-Related Eruptions

Eleonora Anci

Frontiers in Pharmacology, 2021

View PDFchevron_right

GENERALIZED URTICARIA AS A VASCULITIC MANIFESTATION IN A PATIENT WITH SARS-CoV-2 INFECTION: A CASE REPORT IN COLOMBIA

nubia rojas

Journal of Experimental Biology and Agricultural Sciences, 2021

View PDFchevron_right

COVID‐19 and COVID‐19 vaccine‐related dermatological reactions: An interesting case series with a narrative review of the potential critical and non‐critical mucocutaneous adverse effects related to virus, therapy, and the vaccination

Milad Gholizadeh Mesgarha

Clinical Case Reports

View PDFchevron_right